These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33404652)

  • 21. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
    Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
    Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study.
    Wallace BI; Lin P; Kamdar N; Noureldin M; Hayward R; Fox DA; Curtis JR; Saag KG; Waljee AK
    Semin Arthritis Rheum; 2020 Apr; 50(2):228-236. PubMed ID: 31522762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.
    Ferraz-Amaro I; Seoane-Mato D; Sánchez-Alonso F; Martín-Martínez MA;
    Rheumatol Int; 2015 Nov; 35(11):1825-36. PubMed ID: 26403284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.
    Day AL; Curtis JR
    Curr Opin Rheumatol; 2019 May; 31(3):264-270. PubMed ID: 30870218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.
    Kalkan A; Husberg M; Hallert E; Roback K; Thyberg I; Skogh T; Carlsson P
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1679-85. PubMed ID: 26097219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.
    Clinard F; Bardou M; Sgro C; Lefevre N; Raphael F; Paille F; Dumas M; Hillon P; Bonithon-Kopp C
    Eur J Clin Pharmacol; 2001 Dec; 57(10):737-43. PubMed ID: 11829204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis.
    Bae SC; Corzillius M; Kuntz KM; Liang MH
    Rheumatology (Oxford); 2003 Jan; 42(1):46-53. PubMed ID: 12509612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of rheumatoid polyarthritis: evolution of concepts and strategies].
    Dubost JJ; Soubrier M; Sauvezie B
    Rev Med Interne; 1999 Feb; 20(2):171-8. PubMed ID: 10227098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.
    Meuwesen WP; du Plessis JM; Burger JR; Lubbe MS; Cockeran M
    Int J Clin Pharm; 2016 Aug; 38(4):863-9. PubMed ID: 27091130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study.
    Angelici L; Addis A; Agabiti N; Kirchmayer U; Davoli M; Belleudi V
    Medicine (Baltimore); 2021 May; 100(19):e25943. PubMed ID: 34106665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis.
    Munson JC; Kreider M; Chen Z; Christie JD; Kimmel SE
    Br J Clin Pharmacol; 2010 Jul; 70(1):118-25. PubMed ID: 20642554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector.
    Olivier N; Lubbe M; Joubert R; Naudé A; Burger J
    Value Health Reg Issues; 2018 Sep; 16():99-105. PubMed ID: 30227362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.
    van Mater H; Balevic SJ; Freed GL; Clark SJ
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):268-274. PubMed ID: 28464558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
    Levy D
    J Rheumatol; 2014 Oct; 41(10):1903-5. PubMed ID: 25275091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.